Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 61 to 65 of 65 entries
Sorted by: Best Match Show Resources per page
Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension.

Frontiers in cardiovascular medicine

Martin B, Vanderpool RR, Henry BL, Palma JB, Gabris B, Lai YC, Hu J, Tofovic SP, Reddy RP, Mora AL, Gladwin MT, Romero G, Salama G.
PMID: 34295927
Front Cardiovasc Med. 2021 Jul 06;8:668222. doi: 10.3389/fcvm.2021.668222. eCollection 2021.

Pulmonary arterial hypertension (PAH) leads to right ventricular cardiomyopathy and cardiac dysfunctions where in the clinical setting, cardiac arrest is the likely cause of death, in ~70% of PAH patients. We investigated the cardiac phenotype of PAH hearts and...

Cite
Martin B, Vanderpool RR, Henry BL, et al. Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension. Front Cardiovasc Med. 2021;8:668222doi: 10.3389/fcvm.2021.668222.
Martin, B., Vanderpool, R. R., Henry, B. L., Palma, J. B., Gabris, B., Lai, Y. C., Hu, J., Tofovic, S. P., Reddy, R. P., Mora, A. L., Gladwin, M. T., Romero, G., & Salama, G. (2021). Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension. Frontiers in cardiovascular medicine, 8668222. https://doi.org/10.3389/fcvm.2021.668222
Martin, Brian, et al. "Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension." Frontiers in cardiovascular medicine vol. 8 (2021): 668222. doi: https://doi.org/10.3389/fcvm.2021.668222
Martin B, Vanderpool RR, Henry BL, Palma JB, Gabris B, Lai YC, Hu J, Tofovic SP, Reddy RP, Mora AL, Gladwin MT, Romero G, Salama G. Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension. Front Cardiovasc Med. 2021 Jul 06;8:668222. doi: 10.3389/fcvm.2021.668222. eCollection 2021. PMID: 34295927; PMCID: PMC8290063.
Copy Download .nbib Format: NLM
Effects of tDCS during inhibitory control training on performance and PTSD, aggression and anxiety symptoms: a randomized-controlled trial in a military sample.

Psychological medicine

Smits FM, Geuze E, Schutter DJLG, van Honk J, Gladwin TE.
PMID: 33757606
Psychol Med. 2021 Mar 24;1-11. doi: 10.1017/S0033291721000817. Epub 2021 Mar 24.

BACKGROUND: Post-traumatic stress disorder (PTSD), anxiety, and impulsive aggression are linked to transdiagnostic neurocognitive deficits. This includes impaired inhibitory control over inappropriate responses. Prior studies showed that inhibitory control can be improved by modulating the right inferior frontal gyrus...

Cite
Smits FM, Geuze E, Schutter DJLG, et al. Effects of tDCS during inhibitory control training on performance and PTSD, aggression and anxiety symptoms: a randomized-controlled trial in a military sample. Psychol Med. 2021;1-11doi: 10.1017/S0033291721000817.
Smits, F. M., Geuze, E., Schutter, D. J. L. G., van Honk, J., & Gladwin, T. E. (2021). Effects of tDCS during inhibitory control training on performance and PTSD, aggression and anxiety symptoms: a randomized-controlled trial in a military sample. Psychological medicine, 1-11. https://doi.org/10.1017/S0033291721000817
Smits, Fenne M, et al. "Effects of tDCS during inhibitory control training on performance and PTSD, aggression and anxiety symptoms: a randomized-controlled trial in a military sample." Psychological medicine vol. (2021): 1-11. doi: https://doi.org/10.1017/S0033291721000817
Smits FM, Geuze E, Schutter DJLG, van Honk J, Gladwin TE. Effects of tDCS during inhibitory control training on performance and PTSD, aggression and anxiety symptoms: a randomized-controlled trial in a military sample. Psychol Med. 2021 Mar 24;1-11. doi: 10.1017/S0033291721000817. Epub 2021 Mar 24. PMID: 33757606.
Copy Download .nbib Format: NLM
Information about foot care provided to people with diabetes with or without their partners: Impact on recommended foot care behavior.

Applied psychology. Health and well-being

Reaney M, Gladwin T, Churchill S.
PMID: 34761530
Appl Psychol Health Well Being. 2021 Nov 10; doi: 10.1111/aphw.12314. Epub 2021 Nov 10.

BACKGROUND: Many people with diabetes will develop foot ulcers. To reduce risk, it is recommended that the feet are protected against harm and checked daily. Spouses can help people with diabetes care for their feet.METHODS: A randomized parallel arm...

Cite
Reaney M, Gladwin T, Churchill S. Information about foot care provided to people with diabetes with or without their partners: Impact on recommended foot care behavior. Appl Psychol Health Well Being. 2021;doi: 10.1111/aphw.12314.
Reaney, M., Gladwin, T., & Churchill, S. (2021). Information about foot care provided to people with diabetes with or without their partners: Impact on recommended foot care behavior. Applied psychology. Health and well-being, . https://doi.org/10.1111/aphw.12314
Reaney, Matthew, et al. "Information about foot care provided to people with diabetes with or without their partners: Impact on recommended foot care behavior." Applied psychology. Health and well-being vol. (2021). doi: https://doi.org/10.1111/aphw.12314
Reaney M, Gladwin T, Churchill S. Information about foot care provided to people with diabetes with or without their partners: Impact on recommended foot care behavior. Appl Psychol Health Well Being. 2021 Nov 10; doi: 10.1111/aphw.12314. Epub 2021 Nov 10. PMID: 34761530.
Copy Download .nbib Format: NLM
Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness.

JCI insight

Roubinian NH, Reese SE, Qiao H, Plimier C, Fang F, Page GP, Cable RG, Custer B, Gladwin MT, Goel R, Harris B, Hendrickson JE, Kanias T, Kleinman S, Mast AE, Sloan SR, Spencer BR, Spitalnik SL, Busch MP, Hod EA.
PMID: 34793330
JCI Insight. 2022 Jan 11;7(1). doi: 10.1172/jci.insight.152598.

BACKGROUNDRBC transfusion effectiveness varies due to donor, component, and recipient factors. Prior studies identified characteristics associated with variation in hemoglobin increments following transfusion. We extended these observations, examining donor genetic and nongenetic factors affecting transfusion effectiveness.METHODSThis is a multicenter...

Cite
Roubinian NH, Reese SE, Qiao H, et al. Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness. JCI Insight. 2022;7(1)doi: 10.1172/jci.insight.152598.
Roubinian, N. H., Reese, S. E., Qiao, H., Plimier, C., Fang, F., Page, G. P., Cable, R. G., Custer, B., Gladwin, M. T., Goel, R., Harris, B., Hendrickson, J. E., Kanias, T., Kleinman, S., Mast, A. E., Sloan, S. R., Spencer, B. R., Spitalnik, S. L., Busch, M. P., Hod, E. A. (2022). Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness. JCI insight, 7(1), . https://doi.org/10.1172/jci.insight.152598
Roubinian, Nareg H, et al. "Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness." JCI insight vol. 7,1 (2022). doi: https://doi.org/10.1172/jci.insight.152598
Roubinian NH, Reese SE, Qiao H, Plimier C, Fang F, Page GP, Cable RG, Custer B, Gladwin MT, Goel R, Harris B, Hendrickson JE, Kanias T, Kleinman S, Mast AE, Sloan SR, Spencer BR, Spitalnik SL, Busch MP, Hod EA. Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness. JCI Insight. 2022 Jan 11;7(1). doi: 10.1172/jci.insight.152598. PMID: 34793330.
Copy Download .nbib Format: NLM
Endothelium Seeing Red: Should We Redefine eNOS as the Endothelial and Erythrocytic NOS?.

Circulation

Gladwin MT.
PMID: 34516300
Circulation. 2021 Sep 14;144(11):890-892. doi: 10.1161/CIRCULATIONAHA.121.055679. Epub 2021 Sep 13.

No abstract available.

Cite
Gladwin MT. Endothelium Seeing Red: Should We Redefine eNOS as the Endothelial and Erythrocytic NOS?. Circulation. 2021;144(11):890-892doi: 10.1161/CIRCULATIONAHA.121.055679.
Gladwin, M. T. (2021). Endothelium Seeing Red: Should We Redefine eNOS as the Endothelial and Erythrocytic NOS?. Circulation, 144(11), 890-892. https://doi.org/10.1161/CIRCULATIONAHA.121.055679
Gladwin, Mark T. "Endothelium Seeing Red: Should We Redefine eNOS as the Endothelial and Erythrocytic NOS?." Circulation vol. 144,11 (2021): 890-892. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.055679
Gladwin MT. Endothelium Seeing Red: Should We Redefine eNOS as the Endothelial and Erythrocytic NOS?. Circulation. 2021 Sep 14;144(11):890-892. doi: 10.1161/CIRCULATIONAHA.121.055679. Epub 2021 Sep 13. PMID: 34516300.
Copy Download .nbib Format: NLM
Showing 61 to 65 of 65 entries